Advanced Medical Optics (EYE) Tops Q4 Views
Advanced Medical Optics, Inc. (NYSE: EYE) reports Q4 EPS of $0.17, ex-items, 3 cents better than the analyst estimate of $0.14. Revenues for the quarter were $285.2 million, versus the consensus of $282.87 million.
On January 12, 2009, AMO and Abbott (NYSE: ABT) announced a definitive agreement for Abbott to acquire AMO for $22 per share in cash, for a total transaction value of approximately $2.8 billion, inclusive of estimated net debt at the time of close. The transaction is expected to close in the first quarter of 2009.
On January 12, 2009, AMO and Abbott (NYSE: ABT) announced a definitive agreement for Abbott to acquire AMO for $22 per share in cash, for a total transaction value of approximately $2.8 billion, inclusive of estimated net debt at the time of close. The transaction is expected to close in the first quarter of 2009.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Patterson Companies, Inc. (PDCO) Tops Q4 EPS by 5c; Guides FY12
- Flowers Foods, Inc. (FLO) Reports In-Line Q1 EPS; Adjusts FY12 EPS Growth Outlook
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
